top of page
Header Background_v2.png
FMC-27-07 ALOHA Clinical Congress_Logo_CHOSEN_v3.png

JULY 9–10, 2027

Alohilani Resort

Honolulu, Hawaii

We are pleased to announce the Inaugural ALOHA Conference: Clinical Congress of Gastroenterology & Hepatology in Hawaii! Join us July 9-10, 2027, in beautiful Honolulu, Hawaii, for this premier educational event.
 

Over the course of this 1.5-day conference, attendees will receive focused, evidence-based updates highlighting the latest clinically relevant advances in the diagnosis and management of gastrointestinal disorders and chronic liver disease. Internationally renowned gastroenterologists and hepatologists will share their expertise through engaging presentations, interactive discussions, and practical insights designed to enhance patient care.
 

We look forward to welcoming you to Hawaii for an exceptional educational experience that combines world-class faculty, cutting-edge clinical content, and meaningful opportunities to connect with colleagues from across the country.

Agenda

Agenda

2:55 PM - 3:10 PM

Break & Visit Exhibits*

Session II: GI Cancers and AI in Endoscopy

3:10 PM - 3:30 PM

Colorectal Cancer Screening in 2027: Colonoscopy, Stool Tests, Blood Tests, and AI

John Carethers, MD

3:30 PM - 3:50 PM

GERD, Barrett's Esophagus, and H. pylori in 2027

 

3:50 PM - 4:10 PM

Role of ESD in Early Neoplasia Management

Mohammad Othman, MD

4:10 PM - 4:30 PM

Advances in AI in GI 

Brennan Spiegel, MD

4:30 PM - 4:45 PM

Panel Disucssion / Q&A

4:45 PM  - 5:15 PM

Lite Reception & Visit Exhibits*

5:15 PM - 6:00 PM

Industry-Sponsored Event*

6:00 PM - 7:00 PM

Reception

shutterstock_1505830766.png
shutterstock_1498183481_v2.png

Friday, July 9, 2027

 

11:00 AM - 11:30 AM

Lunch, Registration, and Visit Exhibits*

11:30 AM - 12:15 PM

Industry-Sponsored Event*

12:15 PM -12:45 PM

Break & Visit Exhibits*

 

12:45 PM - 1:00 PM

Program Overview

 

Session I: Advances in Inflammatory and Immune Mediated Conditions of GI Tract

 

1:00 PM - 1:20 PM

Advances in the Management of Ulcerative Colitis

Siddharth Singh, MD 

 

1:20 PM - 1:40 PM

Advances in the Management of Crohns Disease

Scott Kuwada, MD

1:40 PM - 2:00 PM

Eosinophilic Esophagitis and Eosinophilic Disorders of GI Tract 

Brennan Spiegel, MD

2:00 PM - 2:20 PM

Management of Irritable Bowel Syndrome 

2:20 PM - 2:40 PM

Advances in Celiac Disease 

2:40 PM - 2:55 PM

Panel Disucssion / Q&A

Saturday, July 10, 2027

7:15 AM - 8:00 AM

Industry-Sponsored Event*

8:00 AM - 8:30 AM

Break & Visit Exhibits*

Session III: Steatotic Liver Disease

8:30 AM - 8:50 AM

Mindfulness for Reducing Burn Out
Rohit Loomba, MD

8:50 AM - 9:10 AM

When, How, and Which Therapy to Use in MASH: Resmetirom and/or Semaglutide?
Meena Bansal, MD

 

9:10 AM - 9:30 AM

Role of FGF-21 and the Emerging Therapeutic Landscape

 

9:30 AM - 9:50 AM

NIT Assessment of MASLD, MetALD, and ALD

Meena Bansal, MD

 

9:50 AM - 10:10 AM

Role of Lanifibranor, Dual and Triple Agonists in MASH
Veeral Ajmera, MD

10:10 AM - 10:25 AM

Panel Disucssion / Q&A

10:25 AM - 10:40 AM

Break & Visit Exhibits*

Session IV: Auto-immune and Genetic Conditions of the Liver

10:40 AM - 11:00 AM

Update on PBC and AIH

11:00 AM - 11:20 AM

Update of Primary Sclerosing Cholangitis 
Veeral Ajmera, MD

11:20 AM - 11:40 AM

Update on Genetic Disorders of Cholestasis and Wilson’s Disease

James Hamilton, MD

11:40 AM - 11:55 AM

Panel Disucssion / Q&A

 

11:55 AM - 12:15 PM

Lunch and Visit Exhibits*

​12:15 PM - 1:15 PM

Accredited Symposium

   

Session V: Cirrhosis and Complications

 

1:15 PM - 1:35 PM

Management of Hepatic Encephalopathy in 2027 
Shravan Dave, MD

1:35 PM - 1:55 PM

HCC Screening and Surveillance in 2027
Veeral Ajmera, MD

 

1:55 PM - 2:15 PM

Management of Ascites and SBP in 2027 
Nancy Reau, MD

2:15 PM - 2:35 PM

Emerging Role of AI in Hepatology 

2:35 PM - 2:55 PM

Panel Disucssion / Q&A

2:55 PM - 3:10 PM

Break & Visit Exhibits*

 

Session VI: Viral Hepatitis and Advanced Liver Disease

3:10 PM - 3:30 PM

Current Management of HBV and Functional Cure
Naoky Tsai, MD

3:30 PM - 3:50 PM

Current Management of Delta Hepatitis

Nancy Reau, MD

3:50 PM - 4:10 PM

Emerging Management of AKI, CKD, and HRS in 2027
James Hamilton, MD

4:10 PM - 4:30 PM

New Advances in ACLF in 2027
Veeral Ajmera, MD

4:30 PM - 4:45 PM

Panel Discussion / Q&A 

4:45 PM  

Adjournment

*Non-accredited session.

Faculty To Be Announced 

FMC-26-31 Orange Bottom Swoop.png
Landscape_v1.png

Sponsorship Opportunities
For details on sponsorship opportunities:

© 2026 by Focus Medical Communications, LLC

bottom of page